Organon OGN
NYSE OGN
$13.64 -0.03 (-0.26%)
As of: Sep 10, 2026 · 3:59 PM EDT

Organon (OGN) EBT Margin (2020 - 2026)

Organon (OGN) posted EBT Margin of 11.75% for Q2 2026, down 19.49% on a QoQ basis from 14.59% in Q1 2026, and down 262.0% year-over-year from 7.25% in Q2 2025.

Analysis

Organon (OGN) EBT Margin (2020 - 2026) Analysis & Trends

Organon has reported EBT Margin for 7 years, with the latest figure at 11.75% in Q2 2026.

  • On a quarterly basis, EBT Margin fell 262.0% year-over-year to 11.75% in Q2 2026; TTM through Jun 2026 was 8.01%, a 259.0% decrease from a year earlier, with the FY2025 full-year figure at 6.84%, down 577.0% from the prior year.
  • EBT Margin was 11.75% for Q2 2026 at Organon, down from 14.59% in the prior quarter.
  • The five-year high for EBT Margin was 37.85% in Q4 2022, with the low at 9.82% in Q4 2025.
  • Average EBT Margin over 5 years is 13.8%, with a median of 14.57% recorded in 2024.
  • The sharpest annual moves came in 2022 and 2023: EBT Margin surged 2312 bps in 2022, then slumped 3134 bps in 2023.
  • Over 5 years, EBT Margin stood at 37.85% in 2022, then slumped by 83 bps to 6.51% in 2023, then increased by 25 bps to 8.1% in 2024, then tumbled by 221 bps to 9.82% in 2025, then surged by 220 bps to 11.75% in 2026.
  • The last three EBT Margin figures came in at 11.75% (Q2 2026), 14.59% (Q1 2026), and 9.82% (Q4 2025), per Business Quant data.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) EBT Margin (Qtr)
1 Johnson & Johnson 641.14 Bn 620.38 Bn 17.26 Bn 26.66%
2 AbbVie 451.04 Bn 444.47 Bn 12.70 Bn 25.18%
3 Merck 357.43 Bn 350.29 Bn 12.21 Bn -4.11%
4 Novartis Ag 266.73 Bn 259.04 Bn 11.24 Bn 29.63%
5 Pfizer 157.52 Bn 145.82 Bn 10.94 Bn -4.34%
6 Sanofi 52.14 Bn 44.76 Bn 10.79 Bn 12.17%
7 Revolution Medicines 42.88 Bn 42.88 Bn - -
8 Incyte 24.70 Bn 20.16 Bn 1.57 Bn 44.89%
9 United Therapeutics 21.47 Bn 18.80 Bn 683.80 Mn 47.58%
10 Organon 3.58 Bn 2.45 Bn 847.00 Mn 11.75%
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2026 11.75%
Mar 31, 2026 14.59%
Dec 31, 2025 -9.82%
Sep 30, 2025 15.17%
Jun 30, 2025 14.37%
Mar 31, 2025 6.68%
Dec 31, 2024 8.10%
Sep 30, 2024 13.08%
Jun 30, 2024 14.62%
Mar 31, 2024 14.55%
Dec 31, 2023 6.51%
Sep 30, 2023 5.27%
Jun 30, 2023 15.80%
Mar 31, 2023 15.28%
Dec 31, 2022 37.85%
Sep 30, 2022 18.35%
Jun 30, 2022 18.11%
Mar 31, 2022 28.21%
Dec 31, 2021 14.72%
Sep 30, 2021 24.31%